Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1997 Apr;120(8):1561–1567. doi: 10.1038/sj.bjp.0701065

Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between γ2-MSH and ACTH-(1–24)

Patricia Van Bergen *, Jeroen A Kleijne *, Dick J De Wildt *,†, Dirk H G Versteeg *,*
PMCID: PMC1564623  PMID: 9113379

Abstract

  1. We investigated the effects of [Nle4,D-Phe7]α-melanocyte-stimulating hormone (NDP-MSH), adrenocorticotropin-(124) (ACTH-(124)) and γ2-MSH, three melanocortins with different agonist selectivity for the five cloned melanocortin receptors, on blood pressure and heart rate in conscious, freely moving rats following intravenous administration.

  2. As was previously found by other investigators as well as by us, γ2-MSH, a peptide suggested to be an agonist with selectivity for the melanocortin MC3 receptor, caused a dose-dependent, short lasting pressor response in combination with a tachycardia. Despite the fact that NDP-MSH is a potent agonist of various melanocortin receptor subtypes, among which the melanocortin MC3 receptor, it did not affect blood pressure or heart rate, when administered i.v. in doses of up to 1000 nmol kg−1.

  3. ACTH-(124) caused a dose-dependent decrease in blood pressure in combination with a dose-dependent increase in heart rate in a dose-range from 15 to 500 nmol kg−1. The cardiovascular effects of ACTH-(124) were independent of the presence of the adrenals.

  4. Pretreatment with ACTH-(124) caused a pronounced, dose-dependent parallel shift to the right of the dose-response curve for the pressor and tachycardiac effects of γ2-MSH. The antagonistic effect of ACTH-(124) was already apparent following a dose of this peptide as low as 10 nmol kg−1, which when given alone had no intrinsic hypotensive activity.

  5. These results form further support for the notion that it is not via activation of one of the as yet cloned melanocortin receptors that γ-MSH-like peptides increase blood pressure and heart rate. The cardiovascular effects of ACTH-(124) seem not to be mediated by the adrenal melanocortin MC2 receptors, for which ACTH-(124) is a selective agonist, or by adrenal catecholamines.

  6. There appears to be a functional antagonism between ACTH-(124) and γ2-MSH, two melanocortins derived from a common precursor, with respect to their effect on blood pressure and heart rate. Whether this antagonism plays a (patho)physiological role remains to be shown.

Keywords: γ2-MSH (γ2-melanocyte-stimulating hormone); ACTH-(124) (adrenocorticotropin-(124)); [Nle4,D-Phe7]α-MSH; blood pressure; heart rate; melanocortin receptor subtypes; functional antagonism

Full Text

The Full Text of this article is available as a PDF (379.1 KB).

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES